Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Postinfectious Irritable Bowel Syndrome and Noninfective Irritable Bowel Syndrome With Gelsectan

NCT05045768 is registered in ClinicalTrials.gov with Evangelismos Hospital as lead sponsor.

NCT NCT05045768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05045768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Postinfectious Irritable Bowel Syndrome and Noninfective Irritable Bowel Syndrome With Gelsectan
Lead sponsor
Evangelismos Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2021
Completion date
February 26, 2024
Enrollment
275 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome